Silidine®

By improving microvascular tone, SILIDINE® corrects skin dysfunctions such as face redness, as well as heavy leg syndrome sensations.

Brand: Silidine (2 products)

INCI Name: Porphyridium Cruentum Culture Conditioned Media

Functions: Toning Agent

Labeling Claims: BSE-free, CMR Substances-free, EDTA-free, GMO-free, Gluten-free, Glycol ether-free, Hormones-free, Impurities-free, Nanomaterials-free, Natural, Nitrosamines-free, Non-Irritant, Non-Mutagenic, Non-Phototoxic, Non-Toxic, Not Tested on Animals, Pesticide-free, Phthalates-free, Solvent-free, Sustainable, TSE-free, VOC-free, Vegan

Benefit Claims: Anti-Inflammatory, Blemish Control, Compatibility, Dark Circles Reduction, Hypo-Allergenic, Redness Reduction, Sensitivity Reduction, Stimulating, Suitable for Sensitive Skin, Toning, Venotonic

Certifications & Compliance: CFDA Compliant (China), EU Cosmetic Regulation 1223/2009 Compliant, FDA Compliant, GMP, IECIC (China), ISO 22716

Enhanced TDS

Knowde-enriched technical product data sheet

Identification & Functionality

Carrier
INCI Name
Cosmetic Ingredients Functions
EINECS No.
231-791-2, 246-376-1, 201-069-1, 208-534-8
Technologies
Product Families
Origin
  • Porphiridium Cruentum
  • Citric acid
  • Sodium Benzoate
  • Potassium Sorbate

Features & Benefits

Benefit Claims
Labeling Claims
Action
  • Improves vascular tone
  • Inhibits rosacea and skin redness
  • Corrects heavy leg syndrome
Cosmetic Benefits
  • Skin blemishes such as the redness from rosacea, dark circles, oedemas and micro-inflammationsare reduced. 
  • Venous insufficiency is corrected and the phenomenon of heavy and tired legs is reduced.

Applications & Uses

Treatment Product Applications
Cosmetic Use

Face care products: correction of skin redness and blemishes, sensitive skins.
Body care products: prevention of heavy leg syndrome, toning.

Formulation
  • Concentration for use: 1 to 5%
  • pH for use: 4.0 to 10.0
  • Caution for use: Add to emulsions, at the end of the preparation process, either cold or at 35-40°C, during cooling

Properties

Physical Form
Odor
Characteristic
Appearance
Liquid
Soluble in
Water, 10% in water
Partially Soluble in
10% in ethanol
Quantifications
ValueUnitsTest Method / Conditions
Heavy Metalsmax. 10ppmPh. Eur. 2.4.8 proc C
Total Nitrogen Compounds (Kjeldahl)70 - 100g/LNF EN 25663
Physico-Chemical Properties
ValueUnitsTest Method / Conditions
Dry Matter10.0 - 12.0%GT006
pH Value (Direct)3.4 - 4.0-GT005
Microbiological Values
ValueUnitsTest Method / Conditions
Detection of EnterobacteriaAbsence-ISO 18415
Enumeration of Mesophilic Aerobic Bacteriamax. 100ufc/mL - cfu/mLISO 21149
Enumeration of Yeasts and Moldsmax. 100ufc/mL - cfu/mLISO 16212
Composition

Oligosaccharides
Trace elements: Calcium, Chlorine, Iron, Potassium, Magnesium,
Manganese, Phosphorus

Regulatory & Compliance

Certifications & Compliance
REACH Status
INCI Concentration REACH Status
Aqua 86.55 - 89.55 % Water exempted annex I
Porphyridium Cruentum Culture
Conditioned Media
10 - 12 % Exempt: < 1 ton/year (dry matter)
Citric Acid < 1 % Acide citrique
registered n° 01-2119457026-42
Sodium Benzoate 0.3 % Sodium Benzoate
registered n° 01-2119460683-35
Potassium Sorbate 0.15 % Potassium Sorbate registered n°01-2119950315-41-xxxx

 

Technical Details & Test Data

Mechanism of Action

This micro-algae is a mixture of oligosaccharides and trace elements which stimulate expression of the gene coding for the protein responsible for smooth muscle vessel contraction (endothelin-I), in the capillaries, thereby inducing a constriction and an improvement of micro-circulation. By improving vascular tone, it corrects skin dysfunctions such as rosacea, as well as heavy leg syndrome.

Scientific Process

SILIDINE® stimulates the expression of the endothelin-1 gene (ET-1) and hence the synthesis of this protein by endothelial cells (and fibroblasts) in the capillaries. The binding of ET-I to the surface receptors (ETA and ETB2) of smooth muscle cells induces a signal that diffused from the outside to the inside of the cell membrane and activates several effectors, ultimately leading to vasoconstriction, thus improving vascular tone.

Silidine® - Scientific Process

• ET-1: Endothelin-1
• ETA: Endothelin-1 receptor, sub-type A
• ETB2: Endothelin-1 receptor, sub-type B2
   G: Protein G
• PLC: Phospholipase C
• PIP: Phosphatidyl inositol

• DAG: 1,2-diacylglycerol
• IP3: Inositol 1,4,5 - trisphosphate
• CaM: Calmodulin
• MLCK: Myosin Light Chain Kinase
   LC: Light myosin Chains
• P-LC: Phosphorylated Light myosin Chains

Transcriptomic Analysison DNA Chip

SILIDINE® stimulates the expression of the gene coding for endothelin-1, and hence the synthesis of this protein responsible for vascular smooth muscle contraction.

Silidine® - Transcriptomic Analysison Dna Chip

 

Production

Obtained from the red alga Porphyrium cruentum by the metabolic induction technique.

Silidine® - Production

The Porphyrium cruentum culture is subjected to oxidative stress resulting from an increase in oxygen levels by photosynthesis in the culture medium. Faced with this oxidative stress, the alga adapts its own metabolism to the changing environmental conditions, reacts, synthesizes various molecules of interest such as oligosaccharides and converts the trace elements present in the medium.

Proven Efficacy - In Vivo Tests

EFFECT ON REDNESS
• SILIDINE® reduced facial redness by 19%.The reduction was visible in 86% of volunteers

Silidine® - Proven Efficacy - in Vivo Tests

3% SILIDINE® (liquid) / 28 days / Double blind / 14 volunteers Twice-daily application

Note: * p<0.05

 

Silidine® - Proven Efficacy - in Vivo Tests - 1

SILIDINE® improves vascular tone and helps to reduce the effects of rosacea such as redness.

EFFECT ON HEAVY LEG SYNDROME
• Variation in micro-circulation in 36% of volunteers*

Silidine® - Proven Efficacy - in Vivo Tests - 2

Note: * 1% SILIDINE® (powder) / 28 days / 22 volunteers Twice-daily application

SILIDINE® improves vascular tone and helps to reduce heavy legs syndrome.

 

• SELF-EVALUATION TEST*

More than 70% of volunteers observed an improvement in:
> tired legs sensation
> heavy legs syndrome

Overall evaluation immediately after applying 1% SILIDINE®

Silidine® - Proven Efficacy - in Vivo Tests - 3

 

Efficacy on skin properties

 

Silidine® - Proven Efficacy - in Vivo Tests - 4

 

Efficacy on heavy leg sensations

Silidine® - Proven Efficacy - in Vivo Tests - 5

Note:* 1% SILIDINE® (powder) / 28 days / 22 volunteers Twice-daily application

Safety & Health

Toxicological Tests
Tests Method Tested Concentration Results
Skin Irritation Patch Test 20 % Very good skin compatibility
Eye Irritation Het cam 20 % Pratically non irritant
Sensitization Marzulli-Maibach 10 % Hypoallergenic
Phototoxicity 3T3 cells Product tested at 9 concentrations phototoxic
Mutagenicity test Ames test 10 % Not mutagenic

 

Storage & Handling

Shelf Life
24 months
Storage

15 / +25°C
Keep in the original packaging, without opening, in the recommended storage conditions.
Advice before use : Agitation